Metabolic Syndrome and Obesity in Peritoneal Dialysis

Publication date: Available online 13 January 2016 Source:Kidney Research and Clinical Practice Author(s): Wai Kei Lo Metabolic Syndrome refers to a clustering of features related to increased risk of cardiovascular disease, which include obesity or central obesity, dyslipidemia, diabetes mellitus or insulin resistance, together with hypertension. The prevalence of metabolic syndrome in end-stage renal failure patients on peritoneal dialysis is quite common, ranging from 40 to 60%, depending on the population studied and the definition used. However, there are controversies about the clinical outcome of patients with metabolic syndrome, particularly in the area of obesity. Whether peritoneal dialysis predisposes patients to metabolic syndrome is another unsolved issue. Despite these controversies, preventing patients developing metabolic syndrome is important, at least from a theoretically point of view.
Source: Kidney Research and Clinical Practice - Category: Urology & Nephrology Source Type: research